Zepp Health's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Zepp Health (ZEPP) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Zepp Health vs Its Competitors
- TTM: Trailing 12-month revenue of 258M vs 466,833M combined for tracked competitors (0.1% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs accelerating (+23.2%) for its tracked peer group.
- Growth: Zepp Health generated 41.7% revenue growth year over year in Q4 2025, vs 15.7% for its tracked competitors combined.
- Profitability: Its -15.5% net margin compares with 29.3% for the peer group.
- Scale: Zepp Health ranks #12 of 15 companies by market capitalization in the Computer Hardware industry, holding 0.0% of industry market cap.
- Peer revenue share: Zepp Health accounted for 0.2% of combined revenue among its tracked peer group, up from 0.2% a year earlier.
- Peer differentiation: Revenue per employee of $0.56M compares with $4.10M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ZEPP Sales vs. its Competitors, Q4 2025
Zepp Health reported revenue growth of 41.68 % year on year in Q4 2025, above its competitors' combined revenue growth of 15.65 %.
With a net margin of -15.52 %, Zepp Health reported lower profitability than its competitors (29.27 %).
Zepp Health generated 0.18 % of the combined sales of its peer group, up from 0.15 % a year earlier.
Zepp Health vs. its Competitors, Q4 2025
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Zepp Health and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Zepp Health Corp | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (8) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Zepp Health's competitor groups requires a Commercial License.
For context: the Computer Hardware industry grew revenue 29.2% year over year, combined, vs 41.7% for Zepp Health. Zepp Health's share of combined industry revenue moved from 0.10% to 0.11%, a gain of 0.01 percentage points.
Zepp Health's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Zepp Health Corp | No | Yes | Yes | No |
| Competitors combined (4) | ||||
| High-Confidence Competitors (3) | ||||
| Similar-Size Competitors (8) | ||||
| Similar Growth & Profitability (8) | 75.00 % (6 of 8) | 100.00 % (8 of 8) | 75.00 % (6 of 8) | 0.00 % (0 of 7) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ZEPP Stock Performance relative to its Competitors
ZEPP Stock Performance relative to High-Confidence Competitors
ZEPP Stock Performance relative to Similar-Size Competitors
ZEPP Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Movano Inc | 282.9% | Outperformed |
| 2 | Apple Inc | 282.9% | Outperformed |
| 3 | Vuzix Corp | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Zepp Health's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Zepp Health's Comment on Competition and Industry Peers
Publicly Traded Peers of Zepp Health Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Zepp Health Corp | 989.74 | 258.19 |
| Apple Inc | 4,979,446.36 | 466,823.00 |
| Movano Inc | 281.71 | 4.44 |
| Vuzix Corp | 231.94 | 5.91 |
| Samsung Electronics Co Ltd | - | 215,100.00 |
| SUBTOTAL | 4,980,949.74 | 682,191.53 |
Sources: Zepp Health Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Zepp Health Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Zepp Health's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Garmin Ltd | Named by the company | 85% |
| Samsung | Named by the company | 85% |
| Google Fitbit | Named by the company | 85% |
| Apple | Named by the company | 85% |
| Xiaomi | Named by the company | 85% |
| Huawei | Named by the company | 85% |
| Fitbit | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Zepp Health's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Zepp Health's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Apple Inc | Americas 41.84 % |
| Movano Inc | AI Platform and Services 100.00 % |
| Vuzix Corp | Single Reportable Segment 100.00 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Zepp Health's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Zepp Health Corp | 990 | 555,247 | -86,168 |
| Apple Inc | 4,979,446 | 2,812,187 | 776,687 |
| Movano Inc | 282 | 110,875 | -691,300 |
| Vuzix Corp | 232 | 67,145 | -348,514 |
| Samsung Electronics Co Ltd | - | - | - |
| PEERS TOTAL | 4,979,960 | 4,104,867 | 775,737 |
Zepp Health's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Zepp Health Corp | Europe 42.71 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Zepp Health's Position in Industry Market Structure
Market-capitalization share and concentration across all 15 companies in Zepp Health's industry classification, broader than the peer set above. Market cap in millions of $.Zepp Health ranks #12 of 15 companies by market capitalization in its industry, holding 0.02 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 6,157, indicating a highly concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Apple Inc | 4,979,446 | 77.96 % |
| 2 | Dell Technologies Inc | 354,369 | 5.55 % |
| 3 | Sandisk Corporation | 265,498 | 4.16 % |
| 4 | Seagate Technology Holdings Plc | 211,026 | 3.30 % |
| 5 | International Business Machines Corporation | 1,234 | 5.2% |
| 6 | Western Digital Corporation | 1,234 | 5.2% |
| 7 | Hewlett Packard Enterprise Company | 1,234 | 5.2% |
| 8 | Netapp Inc | 1,234 | 5.2% |
| 9 | Super Micro Computer Inc | 1,234 | 5.2% |
| 10 | Hp inc | 1,234 | 5.2% |
| 12 | Zepp Health Corp | 990 | 0.02 % |
Market cap and industry share for the rest of Zepp Health's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Zepp Health's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 7 | Hewlett Packard Enterprise Company | 90,758 | 158.05 % |
| 8 | Netapp Inc | 40,882 | 67.55 % |
| 9 | Super Micro Computer Inc | 29,135 | -7.87 % |
| 10 | Hp inc | 1,234 | 12.3% |
| 11 | Omnicell inc | 1,234 | 12.3% |
| 12 | Zepp Health Corp | 990 | -91.21 % |
| 13 | Quantum Corp | 1,234 | 12.3% |
| 14 | One Stop Systems Inc | 1,234 | 12.3% |
| 15 | Socket Mobile Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Zepp Health's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Zepp Health's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Computer Hardware industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (21 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 5.35 % | 43.10 % (avg) | -37.8 pp |
| Operating Margin | -1.58 % | industry median | -5.3 pp |
| EBITDA Margin | -0.71 % | 10.35 % (avg) | -11.1 pp |
| Capital Intensity (Capex / Revenue) | 0.10 % | 2.38 % (avg) | -2.3 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Zepp Health's Valuation vs Competitive Position
Valuation multiples vs the Computer Hardware industry average (21 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 33.7x | - |
| EV / EBITDA | - | 20.6x | - |
| P/B | 42.3x | 9.0x | +33.3x |
| Return on Equity | -18.68 % | industry aggregate | -119.05 % |
| Return on Invested Capital | -0.82 % | 10.31 % (avg) | -11.13 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Zepp Health's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | -41.62 % | -48.03 % | 41.68 % |
| Operating Margin | -1.23 % | -3.60 % | -1.58 % |
| Return on Invested Capital | -0.52 % | -1.12 % | -0.82 % |
| P/E | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Zepp Health's Strategic Group Map
Every company in Zepp Health's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Zepp Health is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Zepp Health's BCG Growth-Share Matrix
Relative market share (vs Zepp Health's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Zepp Health falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 9.0% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Apple Inc alone holds 78% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Zepp Health's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 6,157 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.10 % vs industry average 2.38 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Zepp Health's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Zepp Health's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Zepp Health's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Zepp Health falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Zepp Health's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
- Operating margin 5.3 points below the industry median.
- Return on equity 119.1 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
Opportunities
No rule matched.
Threats
- Industry dominated by Apple Inc , holding 77.96 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Zepp Health's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Zepp Health Corp | 0.20 | 1.02 | 0.80 |
| Apple Inc | 0.26 | 0.96 | 0.99 |
| Movano Inc | 1.14 | 1.55 | 0.01 |
| Vuzix Corp | 4.87 | 6.12 | - |
| Samsung Electronics Co Ltd | - | - | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Zepp Health's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Zepp Health Corp | Q4 2025 | +41.7 % | - |
| Apple Inc | Q2 2026 | +16.4 % | +27.1 % |
| Movano Inc | Q2 2026 | +3,590.3 % | - |
| Vuzix Corp | Q2 2026 | -14.1 % | - |
| Samsung Electronics Co Ltd | Q2 2025 | +2.9 % | - |
| PEERS TOTAL | +11.6 % | +27.3 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Zepp Health's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Zepp Health Corp | Q4 2025 | +42.3 % | +208.0 % |
| Apple Inc | Q2 2026 | +8.6 % | -29.1 % |
| Movano Inc | Q2 2026 | - | - |
| Vuzix Corp | Q2 2026 | -14.5 % | -57.9 % |
| Samsung Electronics Co Ltd | Q2 2025 | - | - |
Zepp Health's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Zepp Health Corp | - | - | - |
| Apple Inc | 35.02% | 60.14% | 142.67% |
| Movano Inc | - | - | - |
| Vuzix Corp | - | - | - |
| Samsung Electronics Co Ltd | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Zepp Health's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Zepp Health Corp | - | 3.83 |
| Apple Inc | 38.90 | 10.67 |
| Movano Inc | - | 63.52 |
| Vuzix Corp | - | 39.25 |
| Samsung Electronics Co Ltd | - | - |
| PEERS AVERAGE | 38.66 | 7.30 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.